Proposition 14 permits the state to sell $5.5 billion in general obligation bonds primarily for stem cell research and the development of new medical treatments in California. Specifically, the measure would fund grants to support research and the development of treatments (including clinical trials) for specific diseases. In addition, the proposition directs the California Institute for Regenerative Medicineto (CIRM) to set aside up to 7.5 percent of bond funds for training opportunities for students at the California State University and the California community colleges, as well as providing assistance in establishing and supporting facilities focused on research and clinical trials. The measure also makes numerous changes to CIRM including improving patient access, hiring additional staff, increasing the number of members on CIRM’s governing board, and creating an advisory group to facilitate the new rules.
no polls available for this proposition at this time
- California Choices
- KCET Ballot Brief
- League of Women Voters
- Legislative Analyst's Office
- Project for an Informed Electorate
- Voter's Edge